IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
Relative valuation derived from Financials sector median benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Multiples adjusted for extreme outliers and non-recurring volatility.
Auditing capital efficiency...
Quality Profile Audit
Score: 68.4GRADE B
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation.
Return on Equity
Profit generated per dollar of shareholder equity
8.6%
Sector: 8.5%
Dividend Analysis audit
INCOME
4.55%
Trailing Yield
$4.55
Per $100 Invested
Solid dividend yield for income-focused strategies.
Est. Payout Ratio
142%HIGH
Analyst Projections
Analyst Consensus
Unlock Valuation Tools
Sign up for free access to institutional-quality research tools.
Based on our 6-factor quantitative model, NATIONAL HEALTH INVESTORS INC (NHI) receives a "Hold" rating with a composite score of 55.6/100, ranked #549 out of 4446 stocks. Key factor scores: Quality 68/100, Value 57/100, Momentum 51/100. This is quantitative analysis only — not investment advice.
NATIONAL HEALTH INVESTORS INC (NHI) Stock Analysis — April 2026 Rating, Price, and Forecast
Company Overview — What Does NATIONAL HEALTH INVESTORS INC Do?
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. NATIONAL HEALTH INVESTORS INC (NHI) is classified as a mid-cap stock in the Financials sector, specifically within the Trading industry. The company is led by CEO D. Eric Mendelsohn and employs approximately 20 people, headquartered in Baltimore, Tennessee. With a market capitalization of $4.0B, NHI is one of the notable companies in the Financials sector.
NATIONAL HEALTH INVESTORS INC (NHI) Stock Rating — Hold (April 2026)
As of April 2026, NATIONAL HEALTH INVESTORS INC receives a Hold rating with a composite score of 55.6/100 and 3 out of 5 stars from the Blank Capital Research quantitative model.NHI ranks #549 out of 4,446 stocks in our coverage universe. Within the Financials sector, NATIONAL HEALTH INVESTORS INC ranks #174 of 891 stocks, placing it in the top quartile of its Financials peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).
NHI Stock Price and 52-Week Range
NATIONAL HEALTH INVESTORS INC (NHI) currently trades at $86.48. The stock gained $0.38 (0.4%) in the most recent trading session. The 52-week high for NHI is $91.38, which means the stock is currently trading -5.4% from its annual peak. The 52-week low is $66.41, putting the stock 30.2% above its annual trough. Recent trading volume was 235K shares, suggesting relatively thin trading activity.
Is NHI Overvalued or Undervalued? — Valuation Analysis
NATIONAL HEALTH INVESTORS INC (NHI) carries a value factor score of 57/100 in the Blank Capital model, indicating fair valuation relative to historical norms. The trailing price-to-earnings ratio is 31.29x, compared to the Financials sector average of 14.88x — a premium of 110%. The price-to-book ratio stands at 2.68x, versus the sector average of 1.22x. The price-to-sales ratio is 11.64x, compared to 0.90x for the average Financials stock. On an enterprise value basis, NHI trades at 31.89x EV/EBITDA, versus 3.26x for the sector.
Overall, NHI's valuation appears roughly in line with sector benchmarks, suggesting the market is pricing the stock fairly given its current fundamentals and growth trajectory. Neither deep value nor significantly overpriced, the stock occupies a middle ground on valuation.
NATIONAL HEALTH INVESTORS INC Profitability — ROE, Margins, and Quality Score
NATIONAL HEALTH INVESTORS INC (NHI) earns a quality factor score of 68/100, indicating solid business quality with consistent operational execution. The return on equity (ROE) is 8.6%, compared to the Financials sector average of 8.5%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at 4.7% versus the sector average of 1.2%.
On a margin basis, NATIONAL HEALTH INVESTORS INC reports gross margins of 100.0%. The operating margin is 36.5% (sector: 21.8%). Net profit margin stands at 37.1%, versus 17.7% for the average Financials stock. Revenue growth is running at 5.7% on a trailing basis, compared to 9.4% for the sector. The overall profitability profile is adequate, though there may be room for margin expansion.
NHI Debt, Balance Sheet, and Financial Health
NATIONAL HEALTH INVESTORS INC has a debt-to-equity ratio of 82.0%, compared to the Financials sector average of 121.0%. Leverage is within a manageable range for the industry, though investors should monitor debt trends over time. The current ratio is 2.23x, indicating strong short-term liquidity. Total debt on the balance sheet is $1.11B. Cash and equivalents stand at $82M.
NHI has a beta of 0.16, meaning it is less volatile than the S&P 500, making it a relatively defensive holding. The stability factor score for NATIONAL HEALTH INVESTORS INC is 94/100, indicating low-volatility characteristics and consistent price behavior that appeals to risk-averse investors.
NATIONAL HEALTH INVESTORS INC Revenue and Earnings History — Quarterly Trend
In TTM 2026, NATIONAL HEALTH INVESTORS INC reported revenue of $353M and earnings per share (EPS) of $3.03. Net income for the quarter was $131M. Gross margin was 100.0%. Operating income came in at $129M.
In FY 2025, NATIONAL HEALTH INVESTORS INC reported revenue of $376M and earnings per share (EPS) of $3.03. Net income for the quarter was $141M. Revenue grew 12.1% year-over-year compared to FY 2024. Operating income came in at $137M.
In Q3 2025, NATIONAL HEALTH INVESTORS INC reported revenue of $90M and earnings per share (EPS) of $0.69. Net income for the quarter was $32M. Revenue grew 8.3% year-over-year compared to Q3 2024. Operating income came in at $32M.
In Q2 2025, NATIONAL HEALTH INVESTORS INC reported revenue of $91M and earnings per share (EPS) of $0.79. Net income for the quarter was $37M. Revenue grew 6.7% year-over-year compared to Q2 2024. Operating income came in at $35M.
Over the past 8 quarters, NATIONAL HEALTH INVESTORS INC has demonstrated a growth trajectory, with revenue expanding from $85M to $353M. Investors analyzing NHI stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.
NHI Dividend Yield and Income Analysis
NATIONAL HEALTH INVESTORS INC (NHI) currently pays a dividend yield of 4.5%. At this yield, a $10,000 investment in NHI stock would generate approximately $$455.00 in annual dividend income. This compares to the Financials sector average dividend yield of 2.5%, meaning NHI offers above-average income for its sector. With a net margin of 37.1%, the dividend appears well-covered by earnings, suggesting sustainable payouts going forward.
NHI Momentum and Technical Analysis Profile
NATIONAL HEALTH INVESTORS INC (NHI) has a momentum factor score of 51/100, reflecting neutral trend characteristics. The stock is neither significantly outperforming nor underperforming the broader market on a momentum basis. The investment factor score is 31/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 13/100 signals elevated short interest, which can indicate bearish sentiment among institutional investors.
NHI vs Competitors — Financials Sector Ranking and Peer Comparison
Comparing NHI against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full NHI vs S&P 500 (SPY) comparison to assess how NATIONAL HEALTH INVESTORS INC stacks up against the broader market across all factor dimensions.
NHI Next Earnings Date
No upcoming earnings date has been announced for NATIONAL HEALTH INVESTORS INC (NHI) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.
Should You Buy NHI? — Investment Thesis Summary
NATIONAL HEALTH INVESTORS INC presents a balanced picture with arguments on both sides. The quality score of 68/100 indicates above-average profitability and business fundamentals. Low volatility (stability score 94/100) reduces downside risk.
In summary, NATIONAL HEALTH INVESTORS INC (NHI) earns a Hold rating with a composite score of 55.6/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on NHI stock.
We'll email you when stocks you follow change their composite rating.
Institutional Research Dossier
NATIONAL HEALTH INVESTORS INC (NHI) Deep Dive Analysis
Published on March 24, 2026
Action RatingHold
Sections
Executive Summary
National Health Investors (NHI) receives a Hold rating, reflecting a balanced view of its strengths and weaknesses. While NHI demonstrates strong profitability and stability within the healthcare REIT sector, its relatively high valuation and negative free cash flow raise concerns. The company's focus on need-driven senior housing and medical investments provides a degree of defensiveness, but its growth prospects appear limited given the current macroeconomic environment and the competitive landscape.
The primary takeaway is that NHI is a well-managed REIT with a solid track record, but its current price may not fully compensate investors for the risks associated with its leverage and reliance on external financing. Investors should closely monitor NHI's ability to generate positive free cash flow and maintain its occupancy rates in the face of rising interest rates and potential economic slowdown.
Business Strategy & Overview
National Health Investors operates as a real estate investment trust (REIT) specializing in the healthcare sector. Its core strategy revolves around acquiring, financing, and leasing properties to operators of senior housing facilities, skilled nursing facilities, medical office buildings, and specialty hospitals. NHI generates revenue primarily through lease payments from its tenants, as well as interest income from mortgage and mezzanine financing arrangements. The company's focus on need-driven senior housing aims to provide a stable revenue stream, as demand for these services is less sensitive to economic cycles compared to discretionary spending.
NHI's strategic positioning involves forging partnerships with experienced operators in the senior housing and healthcare industries. By carefully selecting tenants with strong track records and operational expertise, NHI seeks to minimize the risk of lease defaults and property vacancies. The company also employs a diversified investment approach, spreading its capital across various property types and geographic locations to mitigate concentration risk. This diversification strategy is crucial for maintaining a stable and predictable income stream.
The company's growth strategy involves a combination of acquisitions, development projects, and financing arrangements. NHI actively seeks to acquire existing properties that align with its investment criteria, as well as to develop new facilities in underserved markets. The company also provides financing solutions to operators who may not have access to traditional sources of capital, thereby expanding its investment opportunities. However, the current high interest rate environment may constrain NHI's ability to pursue new acquisitions and development projects, potentially limiting its growth prospects.
NHI operates within a highly competitive landscape, facing competition from other healthcare REITs, private equity firms, and traditional real estate investors. The company's ability to differentiate itself through its focus on need-driven senior housing and its strong relationships with operators is crucial for maintaining its competitive edge. Furthermore, NHI must navigate the complex regulatory environment governing the healthcare industry, including compliance with federal and state regulations related to patient care and reimbursement rates. Changes in these regulations could significantly impact the profitability of NHI's tenants and, consequently, the company's rental income.
Execution Benchmarks audit
Revenue Growth
YOY expansion rate
5.7%
Sector: 9.4%
-39% VS SCTR
Economic Moat Analysis
National Health Investors possesses a narrow economic moat, primarily derived from its specialized expertise and established relationships within the healthcare real estate sector. While the REIT business model inherently lacks the strong network effects or high switching costs typically associated with wide-moat companies, NHI's deep understanding of the senior housing and medical property markets provides a competitive advantage. This expertise allows NHI to identify and assess investment opportunities more effectively than generalist real estate investors, leading to potentially higher returns and lower risk.
The company's established relationships with experienced operators in the senior housing and healthcare industries also contribute to its narrow moat. These relationships provide NHI with access to proprietary deal flow and valuable insights into the operational performance of its properties. By partnering with reputable operators, NHI can reduce the risk of lease defaults and property vacancies, thereby enhancing the stability of its income stream. However, these relationships are not exclusive and can be replicated by other REITs with sufficient resources and industry knowledge.
NHI's focus on need-driven senior housing provides a degree of defensiveness, as demand for these services is relatively inelastic. This inelasticity helps to insulate NHI from economic downturns and fluctuations in consumer spending. However, the company's reliance on government reimbursement programs, such as Medicare and Medicaid, exposes it to regulatory risk. Changes in reimbursement rates or eligibility criteria could significantly impact the profitability of NHI's tenants and, consequently, the company's rental income.
The REIT structure itself provides a limited form of cost advantage, as REITs are typically exempt from corporate income taxes, provided they distribute a significant portion of their earnings to shareholders. This tax advantage allows NHI to generate higher returns on its investments compared to taxable corporations. However, the REIT structure also imposes certain constraints, such as limitations on retained earnings and restrictions on certain types of business activities. These constraints can limit NHI's flexibility and growth potential.
Overall, NHI's narrow moat is based on a combination of specialized expertise, established relationships, and a focus on need-driven senior housing. While these factors provide a competitive advantage, they are not insurmountable, and NHI faces ongoing competition from other healthcare REITs and real estate investors. The company's ability to maintain and expand its moat will depend on its continued ability to identify and assess attractive investment opportunities, forge strong partnerships with operators, and navigate the complex regulatory environment governing the healthcare industry.
Financial Health & Profitability
National Health Investors exhibits a mixed financial profile. The company demonstrates strong profitability, with a TTM net margin of 37.1% and an operating margin of 36.5%, significantly exceeding the sector averages of 17.8% and 22.0%, respectively. This indicates efficient management and a favorable lease structure. The company's ROE of 8.6% is in line with the sector average of 8.5%, suggesting that NHI is generating returns on equity comparable to its peers.
However, NHI's free cash flow (FCF) is a significant concern, with a TTM value of $-174.98 million. This negative FCF indicates that the company is not generating enough cash from its operations to cover its capital expenditures and dividend payments. This reliance on external financing to fund its operations and distributions raises questions about the sustainability of its dividend policy and its ability to pursue future growth opportunities. The quarterly financial history does not provide FCF data, making it difficult to assess the trend in FCF generation.
NHI's balance sheet reflects a moderate level of leverage, with a debt-to-equity ratio of 82.00, lower than the sector average of 115.00. This suggests that NHI is less reliant on debt financing compared to its peers. The company's current ratio of 2.23 indicates a strong liquidity position, suggesting that it has sufficient current assets to cover its current liabilities. However, the company's total debt of $1.11 billion represents a significant financial obligation, particularly in the current high interest rate environment.
Analyzing the quarterly financial history reveals a consistent revenue stream, with revenue ranging from $77.88 million to $90.66 million over the past several quarters. Net income has also been relatively stable, ranging from $28.24 million to $39.45 million. The operating margin has remained consistently above 35%, indicating a stable and profitable business model. The revenue growth of 5.7% is below the sector average of 9.3%, suggesting that NHI's growth prospects may be limited compared to its peers.
In summary, NHI's financial health is characterized by strong profitability and a moderate level of leverage, but its negative free cash flow and below-average revenue growth raise concerns. Investors should closely monitor NHI's ability to generate positive free cash flow and maintain its occupancy rates in the face of rising interest rates and potential economic slowdown.
Valuation Assessment
National Health Investors' valuation presents a mixed picture. The company's P/E ratio of 27.0x is significantly higher than the sector average of 15.5x, suggesting that the stock is relatively expensive compared to its peers. This premium valuation may reflect investors' confidence in NHI's stability and profitability, but it also implies that the stock may be vulnerable to a correction if its growth prospects do not meet expectations.
The company's EV/EBITDA ratio of 4.6x is also higher than the sector average of 3.5x, further supporting the view that NHI is relatively expensive. This metric takes into account the company's debt and cash positions, providing a more comprehensive valuation assessment than the P/E ratio. The higher EV/EBITDA ratio suggests that investors are paying a premium for NHI's earnings relative to its enterprise value.
Given the company's negative free cash flow, a traditional FCF yield analysis is not applicable. This lack of positive FCF further complicates the valuation assessment, as it is difficult to determine the intrinsic value of the company based on its cash-generating ability. Investors must rely on other valuation metrics, such as P/E and EV/EBITDA, to assess the stock's attractiveness.
Considering NHI's relatively high valuation multiples and negative free cash flow, the stock appears to be fairly valued to slightly overvalued. While the company's strong profitability and stability warrant a premium valuation, the lack of positive FCF and below-average revenue growth raise concerns about its long-term growth prospects. Investors should carefully consider these factors before investing in NHI.
A discounted cash flow (DCF) analysis, if feasible with projected positive FCF in the future, would provide a more comprehensive valuation assessment. However, without reliable FCF projections, it is difficult to determine the intrinsic value of the company with a high degree of confidence. The Hold rating reflects this uncertainty and suggests that investors should wait for a more favorable entry point before investing in NHI.
Risk & Uncertainty
National Health Investors faces several specific risks that could negatively impact its financial performance and stock price. One of the most significant risks is tenant concentration. While NHI aims to diversify its portfolio, a substantial portion of its revenue may be derived from a limited number of key tenants. The financial distress or bankruptcy of one or more of these tenants could significantly reduce NHI's rental income and negatively impact its profitability. The company's ability to mitigate this risk depends on its careful tenant selection process and its ability to negotiate favorable lease terms.
Another key risk is regulatory uncertainty. The healthcare industry is subject to extensive and evolving regulations, including those related to reimbursement rates, patient care standards, and licensing requirements. Changes in these regulations could significantly impact the profitability of NHI's tenants and, consequently, the company's rental income. For example, reductions in Medicare or Medicaid reimbursement rates could put financial pressure on skilled nursing facilities, leading to lease defaults or rent concessions. NHI must closely monitor regulatory developments and adapt its business strategy accordingly.
Interest rate risk is also a significant concern, particularly in the current rising interest rate environment. NHI relies on debt financing to fund its acquisitions and development projects. Higher interest rates could increase the company's borrowing costs, reducing its profitability and potentially limiting its ability to pursue new investment opportunities. Furthermore, rising interest rates could put downward pressure on property values, potentially leading to impairments on NHI's real estate portfolio.
Competition from other healthcare REITs and real estate investors poses another risk. The healthcare real estate market is highly competitive, and NHI faces ongoing competition for acquisitions and tenants. The company's ability to maintain its competitive edge depends on its ability to identify and assess attractive investment opportunities, forge strong partnerships with operators, and differentiate itself through its specialized expertise and service offerings.
Bulls Say / Bears Say
The Bull Case
BULL VIEWNHI's focus on need-driven senior housing provides a stable and predictable revenue stream, making it a defensive investment in a volatile market.
BULL VIEWThe company's strong profitability and efficient management, as evidenced by its high operating and net margins, warrant a premium valuation compared to its peers.
BULL VIEWNHI's experienced management team and established relationships with operators position it well to capitalize on the growing demand for senior housing and healthcare services.
The Bear Case
BEAR VIEWNHI's negative free cash flow raises concerns about the sustainability of its dividend policy and its reliance on external financing to fund its operations.
BEAR VIEWThe company's relatively high valuation multiples, combined with its below-average revenue growth, suggest that the stock is overvalued and vulnerable to a correction.
BEAR VIEWRising interest rates and regulatory uncertainty pose significant risks to NHI's financial performance and could negatively impact its profitability and growth prospects.
About the Author
Marques Blank
Founder & Chief Investment Officer, Blank Capital
Marques brings 15 years of institutional finance and investing experience, having overseen financial planning for a $1.6B defense business unit. He developed the proprietary 6-factor quantitative model used to score NHI and 4,400+ other equities.
NATIONAL HEALTH INVESTORS INC exhibits a 575% valuation premium relative to institutional benchmarks. This represents a potential valuation overextension based on current multiples.
Return on Assets
Efficiency of asset utilization
4.7%
Sector: 1.2%
Gross Margin
Pricing power and cost efficiency
100.0%
Sector: 0.0%
Operating Margin
Core business profitability
36.5%
Sector: 21.8%
Net Margin
Bottom-line profitability
37.1%
Sector: 17.7%
Factor Methodology
The Quality factor evaluates the persistence and magnitude of cash flows. Companies with scores >70 exhibit superior competitive moats and financial resilience through economic cycles.
Sector Avg Yield2.48%
Yield Delta+83%
Income Projection audit
A $10,000 investment would generate approximately $455 annually in dividends at the current trailing rate.
